JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, M. J.
Right arrow Articles by Luetje, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, M. J.
Right arrow Articles by Luetje, C. W.

Vol. 299, Issue 1, 385-391, October 2001

Determinants of Agonist Binding Affinity on Neuronal Nicotinic Receptor beta  Subunits

Michael J. Parker1, Scott C. Harvey2 and Charles W. Luetje

Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, Florida

The alpha  and beta  subunits of heteromeric neuronal nicotinic acetylcholine receptors (nAChRs) are thought to contribute "principal" and "complementary" components to the agonist binding site, respectively. At least six loops of amino acid sequence (A, B, and C from alpha ; D, E, and F from beta ) are involved. We demonstrated previously that receptors containing the beta 2 subunit had consistently higher affinities for a variety of agonists than beta 4-containing receptors. For example, the affinity of the alpha 2beta 2 receptor for epibatidine, ACh, nicotine, and dimethylphenylpiperazinium (DMPP) exceeds that of alpha 2beta 4 by 9-, 61-, 87-, and 120-fold, respectively. Using saturation and competition analysis of receptors formed by chimeric beta  subunits coexpressed with alpha 2 in Xenopus laevis oocytes, we have now identified sequence segment 54-63 (corresponding to loop D) as a major determinant of affinity for epibatidine, ACh, nicotine, and DMPP. We then analyzed a series of mutant beta 2 subunits in which each residue that differs between beta 2 and beta 4 in this region was changed from what occurs in beta 2 to what occurs in beta 4. The N55S, V56I, and E63T mutations each resulted in a loss of affinity for ACh and nicotine of 3- to 4-fold, whereas the T59K mutation resulted in a 7-fold loss of ACh and nicotine affinity. These mutations had little or no effect on epibatidine and DMPP affinity. The positive charge introduced by the T59K mutation does not appear to underlie loss of agonist affinity, because a similar loss of affinity was observed when a negative charge (T59D) was introduced at this position.


1 Present Address: Department of Neuroscience, Duke University, Durham, NC 27710.

2 Present Address: ACADIA Pharmaceuticals, Inc., 3911 Sorrento Valley Blvd., San Diego, CA 92121-1402.


0022-3565/01/2991-0385$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
O. Salminen, J. A. Drapeau, J. M. McIntosh, A. C. Collins, M. J. Marks, and S. R. Grady
Pharmacology of {alpha}-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice
Mol. Pharmacol., June 1, 2007; 71(6): 1563 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. T. Young, L. M. Broad, R. Zwart, P. C. Astles, M. Bodkin, E. Sher, and N. S. Millar
Species Selectivity of a Nicotinic Acetylcholine Receptor Agonist Is Conferred by Two Adjacent Extracellular beta4 Amino Acids that Are Implicated in the Coupling of Binding to Channel Gating
Mol. Pharmacol., February 1, 2007; 71(2): 389 - 397.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Avalos, M. J. Parker, F. N. Maddox, F. I. Carroll, and C. W. Luetje
Effects of Pyridine Ring Substitutions on Affinity, Efficacy, and Subtype Selectivity of Neuronal Nicotinic Receptor Agonist Epibatidine
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1246 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Le Novere, T. Grutter, and J.-P. Changeux
Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites
PNAS, February 20, 2002; (2002) 42699699.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Le Novere, T. Grutter, and J.-P. Changeux
Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites
PNAS, March 5, 2002; 99(5): 3210 - 3215.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.